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Summary
The archetypal human tumor suppressor p53 is con-
sidered to have unique transactivation properties.
The assumption is based on the fact that additionally
identified human p53 isoforms lack transcriptional ac-
tivity. However, we provide evidence for the existence
of an alternatively spliced p53 isoform (p53) that ex-
erts its transcriptional activity independent from p53.
In contrast to p53, p53 transactivates the endoge-
nous p21 and 14-3-3s but not the mdm2, bax, and
PIG3 promoter. Cell cycle studies showed that p53
displays its differential transcriptional activity only in
damaged S phase cells. Upon activation of the ATR-
intra-S phase checkpoint, p53, but not p53, transac-
tivates the Cdk inhibitor p21. Induction of p21 results
in downregulation of cyclin A-Cdk activity and ac-
cordingly attenuation of S phase progression. Data
demonstrate that the p53-p21-cyclin A-Cdk pathway
is crucial to facilitate uncoupling of repair and replica-
tion events, indicating that p53 is an essential ele-
ment of the ATR-intra-S phase checkpoint.
Introduction
Activation of the tumor suppressor p53 after genotoxic
insults leads to the induction of downstream events
that provide a complex network of signals leading to
cell cycle arrest or apoptosis (Vogelstein et al., 2000).
Both events are in large part due to p53-dependent
transcriptional activation of several downstream genes
including cell cycle regulators (e.g., p21, 14-3-3s, Gadd45)
and proapoptotic factors (e.g., bax and PIGs; El-Deiry,
1998). Since both pathways are activated by p53-medi-
ated transactivation of genes, regulatory mechanisms
must exist to determine the choice of the appropriate
target genes within a given cellular and physiological
context. On the level of the p53 protein, distinct post-
translational modifications and/or binding to other pro-
teins are most likely required to determine the promoter
selectivity of p53 (Appella and Anderson, 2001; An et
al., 2004). The complex regulatory web that mobilizes
p53 after stress is continuously expanding and includes
key checkpoint regulators such as the phosphatidylino-
sitol 3-kinase family members ataxia telangiectasia mu-
tated (ATM) and ATM-Rad3-related protein (ATR) as well*Correspondence: irene.dornreiter@hpi.uni-hamburg.deas the downstream checkpoint kinases Chk2 and Chk1.
Phosphorylation on serine (S) 20 of p53 by Chk2/Chk1
helps to stabilize p53 by uncoupling it from the Mdm2
ubiquitin ligase (Chehab et al., 2000; Hirao et al., 2000),
while ATM/ATR-catalyzed phosphorylation on S-15 par-
ticipates in the activation of p53 (Shiloh, 2001).
Additionally, it was reported that alternative splicing
of p53 is a candidate to regulate the promoter selectiv-
ity of p53 in mouse cells (Arai et al., 1986; Kulesz-Martin
et al., 1994). However, analysis of various human cell
lines failed to detect any equivalent functional C-ter-
minal p53 splice variant (Rehberger et al., 1997; Will et
al., 1995). Yet, an N-terminally truncated human p53-
isoform (p47) has been identified, which is the product
of alternative splicing of p53 (Ghosh et al., 2004). The
alternative splice-derived p47 product is able to control
p53 ubiquitination, cell localization, and activity, but
does not display transcriptional activity.
We now show that alternative splicing of p53 gener-
ates a novel p53 isoform, designated as p53, that is
present in primary and established primate cells of dif-
ferent tissue types. Our results reveal a novel pathway
that operates in the UV-induced ATR-mediated intra-S
phase checkpoint, which depends on the differential
transcriptional activity of p53.
Results
Identification of a Novel p53 Splice Variant
(p53) in Primate Cells
We used a highly sensitive, nonquantitative nested re-
verse transcription (RT)-PCR-based approach (Cooley
and Bergtrom, 2001) to detect possible alternative
splicing of primate p53. First, the cDNA was amplified
between exon 4 and C-terminal exon 11 by using ap-
propriate sense (E4F) and antisense (E11R) primers.
Second, the PCR reaction was performed with nested
PCR primers to exon 6/7 (E6/7F) and exon E11 (E11bR).
Amplification of exons 6/7–11 generated the expected
520 bp PCR product and one additional 325 bp ampli-
con (Figure 1A). The two PCR products were detected
in primary and established wild-type p53 (wtp53) hu-
man and monkey cells of different tissue types (Figure
1A, lanes 1–6). Both amplicons were also found in mu-
tant p53 (mutp53) primate cells (Figure 1A, lanes 7 and
8), but not in the p53 null cell line H1299 (Figure 1A,
lane 9). Sequence analysis of both bands obtained from
wtp53 cell lines CV-1 and HSC93 revealed that the ma-
jor band (520 bp) represents the regularly spliced p53,
whereas the lower molecular weight band (325 bp) re-
sults from alternative splicing. The alternative splice
product designated as p53 lacks 198 nucleotides that
are located in exons 7, 8, and 9. The deletion junction
contains a donor-site-like splice cassette (CACTGGA)
within the coding exon 7 (nucleotide 767) and an ac-
ceptor-site-like splice cassette (CACTGGA) within the
coding exon 9 (nucleotide 965); the resulting 984 bp
p53 transcript that contains the unique junction of
exon 7 with 9 does not alter the open reading frame
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22Figure 1. RT-PCR Reveals a Novel Alternatively Spliced Form of p53
(A) RT-PCR analysis of RNA derived from wtp53 expressing human placenta (lane 2), bone marrow (lane 3), human (lane 4), and monkey (lane
5) cell lines, primary rhesus kidney cells (lane 6), mutp53-expressing human cell lines (lanes 7 and 8), and human p53 null cells (lane 9). The
amplified 520 bp and 325 bp PCR fragments corresponding to p53 and p53 are indicated. (M) 100 bp DNA ladder.
(B) Identification of the deletion junction CACTGGA in p53, which derived from exons 7 and 9.
(C) Western blot performed with lysates derived from (−)/(+) γ-irradiated primate wtp53 (lanes 1–4) and mutp53 (lanes 5–8) cells to analyze p53
and p53 expression using epitope-specific monoclonal anti-p53 antibodies DO1 (N terminus), ICA9 (C terminus), and DO12 (core domain).
(D) Amino acid sequence of human wtp53 and wtp53 assembled after MALDI-TOF/MS analysis. Identified residues are shown in bold and
residues 257–322, which are deleted in p53, are underlined.
(E) DO12-precipitated p53-derived from (−)/(+) γ-irradiated wtp53 and mutp53 cells was analyzed for complex formation with p53 with anti-
p53 antibody SAPU.(Figure 1B). In rodent cells, p53 is not generated most
tlikely because the sequence CACTGGA in the donor-
and/or the acceptor-site-like splice cassette is not pre- s
fsent (see Figure S1A in the Supplemental Data available
with this article online). M
wImmunoblot was performed to investigate whether
p53 is detectable at the protein level, using a set of d
cmonoclonal anti-p53 antibodies directed against epi-
topes that are retained or deleted in p53. The set in- b
qcluded the anti-p53 antibodies DO1 (N terminus, aa 21–
25), ICA9 (C terminus, aa 388–393), DO12 (core domain, s
taa 256–270), and HO7.1 (core domain: aa 291–300).
Both p53 forms were detected with the N- and C-ter- a
Aminal specific antibodies in γ- or UV-irradiated wtp53
and mutp53 primate cells, whereas the core domain- a
aspecific antibodies DO12 and HO7.1 detected only full-
length (fl) p53, but not p53 (Figure 1C, data not shown a
for UV and HO7.1). Thus, immunoblot analysis using
epitope-specific monoclonal anti-p53 antibodies proved i
ithat the faster migrating form of p53 is not the product
of proteolytic degradation. tIn order to confirm that the observed truncated pro-
ein band is identical with the 984 bp alternative p53-
plice product, p53 and p53 were immunoprecipitated
rom nuclear extracts (Figure S1B) and subjected to
ALDI-TOF mass spectrometry. The tryptic fragments
ere identified by peptide mass fingerprinting using
atabase-matching procedures. The peptide, which
ontains residues 257–322, was not detected in p53
y MALDI-TOF/MS (Figure S1C). The amino acid se-
uence of p53 and the corresponding tryptic map as-
embled after MALDI-TOF/MS showed that the pep-
ides of total p53 and p53 tryptic digests covered 98%
nd 88% of the p53 sequence, respectively (Figure 1D).
lignment of the amino acid sequences of human p53
nd p53 shows the position of the missing 66 residues
nd localization of the anti-p53 antibody epitopes that
re retained or deleted in p53 (Figure S1D).
Since the tetramerization domain (residues 325–356)
s preserved in p53, we investigated whether the p53
soform has the ability to oligomerize. Complex forma-
ion of p53 with p53 was evaluated by IP-Western
p53, Component of the Intra-S Phase Checkpoint
23using anti-fl p53 antibody DO12 to precipitate only p53.
Immunoblot analysis of DO12-precipitated p53 con-
firmed that p53 was not coprecipitated and, therefore,
does not hetero-oligomerize with wtp53 or mutp53 (Fig-
ure 1E). Additionally, the fact that p53 does not in-
teract with p53 was confirmed by GST pull-down assay
using purified baculovirus expressed recombinant GST-
tagged and untagged p53 and p53 (Figures S2A and
S2B). Moreover, the oligomeric state of p53 was ex-
amined with purified baculovirus-expressed recombi-
nant human p53. Data show that p53 forms homodi-
mers and -tetramers (Figure S2C), suggesting that
p53 may exert a function independent from p53.
p53 Displays Differential Transcriptional
Activity Per Se
We first tested in p53 null H1299 cells that stably ex-
press human wt/mutp53, wt/mutp53, or empty vector
(null) in the presence of Dox (Figure 2A, top) whether
p53 is transcriptionally active. The transcriptional re-
sponse of the endogenous p21, 14-3-3s, mdm2, bax,Figure 2. p53 Transactivates Endogenous p53-Inducible Promoters Selectively
(A) Inducible p53 null TO-H1299-wtp53, -mutp53, -wtp53, -mutp53, null (−) cells (−)/(+) Dox were analyzed by Western blot with anti-p53
antibody DO1 for ectopic p53/p53 protein expression (panel 1) and p21, 14-3-3σ, mdm2, bax, and pig3 induction 2 hr post-γ-irradiation (hpi)
using appropriate antibodies (panels 2–6).
(B) Dox-induced p53 null TO-H1299 cell lines as in (A) were treated with formaldehyde 2 hpi and processed for ChIP. Crosslinked p53/p53-
DNA complexes were precipitated with epitope-specific anti-p53 antibodies DO1, ICA9, and DO12. T-Ag-specific monoclonal antibody PAb101
served as negative control. Immunoprecipitates were analyzed by Western blot with anti-p53 antibody SAPU.
(C) ChIP-associated p21, 14-3-3s, mdm2, bax, and PIG3 promoter DNA was identified by PCR. Genomic DNA served as marker for the ChIP-
PCR products. The ethidium bromide-stained bands represent relative amount of the promoter DNA recovered by PCR amplification of DNA
extracted from precipitates as in (B).and PIG3 promoters to induced wtp53 or wtp53 ex-
pression in γ-irradiated TO-H1299 cell lines was first in-
vestigated by Western blot. As expected, wtp53 trans-
activated all of the investigated endogenous promoters
(Figure 2A, lane 2), whereas induction of those promot-
ers was not seen in TO-H1299-mutp53, -mutp53 and
null cells (Figure 2A, lanes 6, 8, and 10). However, ex-
pression of wtp53 resulted in upregulation of endoge-
nous p21 and 14-3-3σ, but not mdm2, bax, and pig3
(Figure 2A, lane 4).
Promoter binding studies further assessed the effect
of wtp53 on p53-dependent promoter activation. Chro-
matin immunoprecipitation (ChIP)-PCR was used for
the investigation, since regulation of transcription from
a chromosomal DNA template can differ from that of a
transiently transfected template (Alberts et al., 1998).
Dox-induced TO-H1299-wtp53, -wtp53, and null cells
were irradiated, and crosslinked p53/p53-DNA com-
plexes precipitated with epitope-specific anti-p53 anti-
bodies DO1, ICA9, and DO12; anti-T-antigen antibody
PAb101 served as negative control. The immunopre-
Cell
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abody SAPU by Western blot. As expected, anti-p53 an-
tibodies DO1 and ICA9 precipitated p53 and p53, F
wwhereas DO12 recognized only p53 (Figure 2B). Associ-
ation of p53 and p53 with p21, 14-3-3s, mdm2, bax, l
oand PIG3 promoter DNA was determined by PCR am-
plification. Results show that in irradiated TO-H1299- e
pwtp53 cells, endogenous p21, 14-3-3s, mdm2, bax, and
PIG3 promoter DNA was recovered from DO1-, ICA9- F
uand DO12-precipitated p53 (Figure 2C, panel 1). In con-
trast, ChIP-PCR performed with TO-H1299-wtp53 t
icells demonstrated that p21 and 14-3-3s, but not mdm2,
bax, and PIG3 promoter DNA was retrieved from DO1- F
nand ICA9-precipitated p53 (Figure 2C, panel 2). As ex-
pected, p53/p53-associated promoter DNA was not
udetected in TO-H1299-mutp53, -mutp53, and null cells
(Figure 2C, panels 3–5). Additionally, RT-PCR amplifica- a
ition demonstrated that induction of endogenous p21,
14-3-3s, mdm2, bax, and PIG3 mRNA was only seen in c
MTO-H1299-wtp53 cells, whereas in wtp53 expressing
cells, the mRNA level of p21 and 14-3-3σ, but not of P
smdm2, bax, and PIG3 was increased (Figure S2D).
Thus, results indicate that p53 displays differential m
ptranscriptional activity per se.
u
Fp53 Is Transcriptionally Active Only
tin Irradiated S Phase Cells
tIt was proposed that a cell cycle-specific regulatory
wmechanism prevents transcriptional activation of p53 in
adamaged S phase cells to avoid premature activation
tof the p53 apoptotic pathway (Gottifredi et al., 2001).
wSince p53 does not transactivate apoptosis-promot-
aing genes, we hypothesized that p53 functions in
damaged S phase cells. The assumption was first in-
vestigated by analyzing the protein and mRNA level of T
ap21 in wtp53 CV-1 cells that were irradiated in G1, early
S, and G2. Stabilization and S-15 phosphorylation of T
oboth p53 proteins, accompanied by an increased level
of p21, was observed 3 hr post-UV and 1 hr post-γ irra- t
odiation in G1, early S, and G2 (Figures S3A and S3B,
data not shown for γ). In order to investigate which p53 G
rform is responsible for p21 induction, association of
p53 and p53 with the p21 promoter was examined by t
nChIP-PCR. p21 promoter binding of p53 was detected
in G1 and G2, but not in S, since p21 promoter DNA a
awas not obtained with anti-fl p53 antibody DO12 (Figure
3A). However, recovery of p21 promoter DNA from DO1 m
uand ICA9 precipitates points to p53-mediated p21
transactivation in S phase (Figure 3A). m
1In view of the fact that p53-specifc antibodies are
not at hand to allow direct discrimination between p53 p
sand p53, wtp53 CV-1 cells were chosen to establish
an inducible cell system that expresses the appropriate
Flag-tagged wt or mutp53/p53 protein or empty vec-
tor (null) upon Dox addition. Inducible Flag-tagged pro- t
itein expression in the respective wtp53 TO-CV-1 cell
line was analyzed by Western blot (Figure 3B). Addi- p
ationally, inactivation of endogenous wtp53 or wtp53,
accomplished by complex formation with the corre- s
Tsponding ectopically expressed Flag-tagged mutp53/
p53, allows studying the physiological impact of en- o
pdogenous wtp53 and wtp53 individually in an isogenic
cell system. Probing the anti-Flag precipitates with cnti-Flag M2 (Figure 3C, top), anti-fl p53 DO12 (middle),
nd anti-p53 DO1 (bottom) antibodies showed that
lag-wtp53 and -mutp53 interacted with endogenous
tp53, but not with endogenous wtp53 (Figure 3C,
anes 1 and 2); precipitated Flag-wtp53 and -mutp53
ligomerized with endogenous wtp53, but not with
ndogenous wtp53 (Figure 3C, lanes 3 and 4). As ex-
ected, anti-fl p53 antibody DO12 did not recognize
lag-wtp53, -mutp53, or endogenous wtp53 (Fig-
re 3C, middle, lanes 3 and 4). ChIP-PCR demonstrated
hat ectopic Flag-mutp53 abrogated p21 promoter bind-
ng of endogenous wtp53 (Figure 3D, panel 1), whereas
lag-mutp53 prevented promoter binding of endoge-
ous wtp53 (Figure 3D, panel 2).
The inducible wtp53 TO-CV-1-Flag cell system was
sed to confirm that p21 promoter association of p53
nd p53 is cell cycle specific. Following UV irradiation
n G1, early S, and G2, crosslinked Flag-p53/p53-DNA
omplexes were precipitated with anti-Flag antibody
2. Anti-fl p53 antibody DO12 and anti-T-Ag antibody
Ab101 were used for the control experiments. Results
how that in Flag-wtp53-expressing cells, p21 pro-
oter DNA was recovered from anti-Flag and anti-fl
53 DO12 precipitates in G1 and G2, but not in S (Fig-
re 3D, panel 3). However, ChIP-PCR performed with
lag-wtp53-expressing cells demonstrates that only
he anti-Flag precipitate derived from S phase con-
ained p21 promoter DNA, whereas p21 promoter DNA
as recovered from G1 and G2 only with anti-fl p53
ntibody DO12 (Figure 3D, panel 4). Thus, data confirm
hat p21 promoter binding of p53 is S phase specific,
hereas p53 binds the p21 promoter exclusively in G1
nd G2.
ranscriptional Activity of p53 and p53 Is Activated
nd Inactivated Consecutively
he observed cell cycle-specific p21 promoter binding
f p53 and p53 suggests that both p53 forms exert
heir transcriptional activity independent from each
ther. Thus, p21 induction was monitored in Dox-induced,
1/S-irradiated wtp53 TO-CV-1 cells until 20 hr postir-
adiation (hpi). Western blot analysis revealed that in
he control cell line wtp53 TO-CV-1 null, where domi-
ant-negative effects do not impair endogenous wtp53
nd wtp53, the p21 level was increased between 2
nd 16 hr hpi (Figure 4A, top). In cells expressing Flag-
utp53, p21 was elevated between 8 and 16 hpi (Fig-
re 4A, middle), whereas in cells expressing Flag-
utp53, p21 upregulation was observed between 2 and
0 hpi (Figure 4A, bottom). Thus, during the first 10 hpi,
21 induction is mediated by p53, whereas p53 is re-
ponsible for p21 upregulation starting 8 hpi.
The observation that p21 is initially transactivated by
p53 and at a later time point by p53 was further inves-
igated by performing ChIP-PCR at 3 and 9 hr post-G1/S
rradiation. Crosslinked p53/p53-DNA complexes were
recipitated with anti-p53 DO1, anti-fl p53 DO12, and
nti-Flag M2 antibodies; anti-T-Ag antibody PAb101
erved as negative control. Data show that in wtp53
O-CV-1 null cells, p21 promoter DNA was associated
nly with the DO1 precipitate 3 hpi, whereas 9 hpi p21
romoter DNA was also recovered from the DO12 pre-
ipitate (Figure 4B, left panels). Crosslinked p53/
p53, Component of the Intra-S Phase Checkpoint
25Figure 3. Differential Transcriptional Activity of Endogenous p53 Is S Phase Specific
(A) Wtp53 CV-1 cells, UV-irradiated in G1, early S, and G2, were treated with formaldehyde 2 hpi and processed for ChIP. Crosslinked p53/
p53-DNA complexes were precipitated with anti-p53 antibodies and associated p21 promoter DNA was identified by PCR as in Figures 2B
and 2C.
(B) Inducible wtp53 TO-CV-1-Flag-wtp53, -mutp53, -wtp53, -mutp53 or null (−) cells (−)/(+) Dox were analyzed for ectopic Flag-p53 protein
expression by Western blot.
(C) Immunoprecipitated Flag-tagged p53 proteins derived from Dox induced wtp53 TO-CV-1 cells as in (B) were analyzed for oligomerization
with endogenous wtp53 and wtp53. Immunoprecipitated Flag-p53 proteins were visualized with anti-Flag antibody M2. Associated endoge-
nous wtp53 and wtp53 (shown in roman) was analyzed with anti-p53 antibody DO1. Antibody DO12 was used to detect only p53.
(D) Dox-induced wtp53 TO-CV-1 cells as in (B) were UV irradiated in G1, early S, and G2, treated with formaldehyde 2 hpi, and processed for
ChIP. Flag-tagged p53 proteins were precipitated with antibody M2; antibody DO12 was used to precipitate only p53. T-Ag-specific antibody
PAb101 served as negative control. Associated p21 promoter DNA was identified by PCR as in Figure 2C.p53-DNA complexes obtained from wtp53 TO-CV-1-
Flag-wtp53 and -wtp53 cells showed that 3 hpi-only
Flag-wtp53 was associated with p21 promoter DNA,
whereas Flag-wtp53 bound the p21 promoter DNA 9
hpi (Figure 4B, middle and right panels). Experiments
performed with cells expressing Flag-mutp53 or -mutp53
showed that Flag-mutp53 caused abrogation of en-
dogenous wtp53 p21 promoter binding 3 hpi (Figure
4C, middle panels), whereas Flag-mutp53 prevented
p21 promoter binding of endogenous wtp53 9 hpi (Fig-
ure 4C, right panels). Accordingly, the results demon-
strate that the transcriptional activity of p53 and p53
is activated and inactivated consecutively and hence
strictly separated.
ATR Is Required for p53-Mediated p21 Induction
Leading to Attenuation of S Phase Progression
Cells, UV irradiated at the G1/S transition, activate the
ATR-signaling pathway that operates through regula-
tory phosphorylation of downstream effector proteins
(Bartek et al., 2004). Since p21 is initially transactivated
by p53, we assumed that p53 is one of the effector
proteins activated early. Thus, CV-1 cells were UV irra-
diated at G1/S, and activation of ATR was confirmed by
the presence of phosphorylated Chk1 (Figure 5A, panel1). Phosphorylation on S-15 was observed for p53
2–8 hpi and for p53 2–20 hpi (Figure 5A, panels 2 and
3), indicating that both p53 proteins were modified by
ATR. Despite the fact that p53 and p53 were stabilized
and phosphorylated on S-15, only p53 was activated
and responsible for early p21 induction (Figure 4B).
However, as soon as the p53 protein level declined 8
hpi, transactivation of p21 was mediated by p53 (Fig-
ures 4B and 5A, panel 4). The observation that ATR is
implicated in p53 activation was further investigated
in Dox-induced, G1/S-irradiated wtp53 TO-CV-1-Flag-
ATRkd cells. The dominant-negative effect of ectopic
Flag-ATRkd did not just prevent phosphorylation of
Chk1 on S-345, but also stabilization, S-15 phosphory-
lation, and transcriptional activation of p53 (Figure
5B). However, 12 hpi and, in the absence of functional
ATR, p21 induction correlated with S-15 phosphoryla-
tion of stabilized p53 (Figure 5B, panels 2–4). The find-
ing was confirmed by treating UV-irradiated wtp53
CV-1 cells with the ATR inhibitor caffeine (Figure 5C).
The physiological implication of the ATR-dependent
p53-mediated p21 transactivation on cell cycle pro-
gression was investigated in G1/S-irradiated wtp53
CV-1 and TO-CV-1 cells. In all mock-treated cells, the
FACS profiles showed that DNA replication was com-
Cell
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5Figure 4. p53 and p53 Are Activated and Inactivated Consecu-
ctively
s(A) Analysis of p21 expression in Dox-induced, G1/S-UV-irradiated
Ewtp53 TO-CV-1-Flag-mutp53, -mutp53, null (−) cells by Western
blot at the indicated hpi. n
(B) Dox induced, G1/S-UV-irradiated wtp53 TO-CV-1-Flag-wtp53, t
-mutp53, null (−) cells were treated with formaldehyde 3 and 9 hpi i
and processed for ChIP. Crosslinked p53/p53-DNA complexes
5were precipitated with anti-p53 DO1, anti-fl p53 DO12, and anti-
cFlag M2 antibodies; anti-T-Ag antibody PAb101 served as negative
Tcontrol. Associated p21 promoter DNA was identified by PCR as in
Figure 2C. a
(C) Dominant-negative effect of Dox-induced Flag-mutp53 and l
-mutp53 expression was analyzed by ChIP-PCR as in (B). h
t
tpleted 8 hpi and cells progressed through G2 to enter
mitosis 4 hr later (Figures 5D, 5E, and S4A). However, t
dG1/S-irradiated wtp53 TO-CV-1 null and CV-1 cells en-
tered G2 12 hpi, indicating that S phase progression r
was delayed significantly (Figures 5D and S4A). Attenu-
ated S phase was also observed in irradiated wtp53 t
tCV-1-Flag-mutp53 cells, where endogenous wtp53 is
inactivated (Figure S4B). In contrast, S phase pro- r
agression was not delayed in Flag-mutp53-expressing
cells, but 10 hpi, those cells accumulated in G2 (Figure m
c5D), indicating that the G2 checkpoint was activated.
Normal cell cycle distribution was observed for all irra- p
mdiated cells 20 hpi, demonstrating that damaging the
cells at the G1/S transition with 10 J/m2 did not affect c
wtheir mitotic cell cycle permanently. Additionally, re-
duced S phase progression upon UV-irradiation was a
balso seen in Dox-induced p53 null TO-H1299-wtp53
cells, but not in uninduced or parental H1299 cells (Fig- Fre S5). Thus, results indicate that following UV irradia-
ion at the G1/S transition p53, but not p53, is acti-
ated by and involved in the ATR-mediated process,
hich attenuates S phase progression.
p53 Attenuates S Phase Progression via
ownregulation of Cyclin A-Cdk Activity
ntry and progression through S phase requires the
ctivities of cyclin E- and cyclin A-Cdk2, respectively,
hereas cyclin A-Cdk1 is required for S/G2 transition
nd G2 progression (Baus et al., 2003). Thus, subse-
uent to G1/S-UV irradiation the observed S phase at-
enuation was most likely caused by downregulation of
hose activities. In all cell lines tested, cyclin E-Cdk2
ctivity dropped immediately due to degradation of the
inase-activating phosphatase Cdc25A and was re-
tored as soon as Cdc25A became stable again (Fig-
res 6A, 6B, S6A, and S6B). Thus, the Cdc25A-medi-
ted inhibition of cyclin E-Cdk2 activity is executed
apidly, independently of p53/p53, but delays S phase
rogression only for 2 hr.
In mock-treated cells, the cyclin A-Cdk activity in-
reased steadily after G1/S transition and declined 12
r later, indicating that cells had progressed through S
nd G2 and were entering mitosis (Figures 6C and S6C).
owever, after irradiating wtp53 TO-CV-1 null and CV-1
ells, the Cdk activity was substantially downregulated
or 8 hr, followed by a moderate but steady increase
Figures 6C and S6C). The finding is in agreement with
he cells’ proliferation profile showing that S phase pro-
ression is attenuated upon G1/S irradiation (Figures
D and S4A). In irradiated, Flag-mutp53-expressing
ells, cyclin A-Cdk activity increased steadily despite a
light delay due to the short Cdc25A-mediated cyclin
-Cdk2 inhibition (Figure 6C). However, 10 hpi, the ki-
ase activity dropped suddenly and prolonged reduc-
ion was observed for the next 5 hr (Figure 6C), confirm-
ng that progression through G2 was delayed (Figure
E). In contrast, irradiated wtp53 TO-CV-1-Flag-mutp53
ells, deficient in functional wtp53, displayed like wtp53
O-CV-1 null cells significant reduction of cyclin A-Cdk
ctivity for the first 8 hpi (Figure 6C), resulting in de-
ayed S phase progression (Figure S4B). However, 8
pi, the decrease in kinase activity was notably lower
han in wtp53 TO-CV-1 null cells. Thus, results show
hat significant reduction in cyclin A-Cdk activity during
he first 8 hr correlates with functional wtp53, whereas
ownregulation of this Cdk activity starting at 8 hpi cor-
elates with functional wtp53.
Downregulation of cyclin A-Cdk activity can be facili-
ated by interaction with p21, thus formation of the pro-
ein complex was evaluated subsequent to G1/S-UV ir-
adiation. First, the association of cyclin A with Cdk2
nd Cdk1 during S and G2 phase progression was
onitored in G1/S mock-treated wtp53 TO-CV-1 null
ells. The level of cyclin A increased during S and G2
rogression (10 hr) and declined when cells entered
itosis (12 hr; Figure 6D, panel 1). Soon after cells
rossed G1/S, cyclin A was increasingly associated
ith Cdk2 during S and S/G2 (0–8 hr), whereas S/G2
nd G2 promoting Cdk1 associated with cyclin A shortly
efore the cells completed the replicative stage (6 hr;
igure 6D, panel 1). As expected, in mock-treated cells,
p53, Component of the Intra-S Phase Checkpoint
27Figure 5. ATR-Mediated Transcriptional Activation of p53 Leads to S Phase Attenuation
(A) Analysis of Chk1 S-345 phosphorylation, stabilization, and S-15 phosphorylation of p53, p53, and p21 induction in G1/S-UV-irradiated
wtp53 CV-1 cells by Western blot.
(B) Effect of dominant-negative inactivation of endogenous ATR on Chk1 S-345 phosphorylation, stabilization, and S-15 phosphorylation of
p53, p53, and p21 induction in Dox-induced, G1/S-UV-irradiated wtp53 TO-CV-1-Flag-ATRkd cells.
(C) Effect of caffeine on stabilization, phosphorylation, and induction of proteins in G1/S-UV-irradiated wtp53 CV-1 cells as in (B).
(D) FACS analysis of Dox-induced, G1/S-mock- or UV-irradiated wtp53 TO-CV-1 null cells that were harvested at the indicated time points
and stained with propidium iodide to measure DNA content (y axis).
(E) FACS analysis of Dox-induced wtp53 TO-CV-1-Flag-mutp53 cells as in (D).the kinase was not associated with p21 (Figure 6D,
panel 1). Thus, the formation of the cyclin A-Cdk2/1
complexes correlates with the activity of the cyclin
A-dependent kinases and reflects undisturbed S and
G2 progression as confirmed by FACS (Figure 5D). Con-
versely, in irradiated wtp53 TO-CV-1 null cells, complex
formation of cyclin A with Cdk2 was extended until 16
hpi, and interaction with G2-promoting factor Cdk1 was
postponed for 2 hr (Figure 6D, panel 2), indicating that
entry into G2 was delayed. Western blot analysis of im-
munoprecipitated cyclin A-Cdk demonstrated associa-
tion with p21 from 2–16 hpi (Figure 6D, panel 2) and
correlated with reduced kinase activity (Figure 6C).
Identical results were obtained from irradiated wtp53
CV-1 cells (Figures S6C and S6D). Concisely, p21-medi-
ated downregulation of cyclin A-Cdk activity attenuates
S phase progression, delaying entry into G2 for at least
4 hr as observed by FACS (Figures 5D and S4A).
In irradiated Flag-mutp53-expressing cells, com-plex formation of cyclin A with Cdk2 and Cdk1 (Figure
6D, panel 3) was identical with the one observed in irra-
diated wtp53 TO-CV-1 null cells (Figure 6D, panel 2).
However, in those cells, cyclin A-Cdk-p21 complexes
were not detected until 8 hpi due to abrogation of
p53-dependent p21 induction (Figure 6D, panel 3).
The finding correlated with the observation that the ki-
nase activity was not substantially reduced during the
first 8 hpi (Figure 6C), resulting in steady S phase pro-
gression (Figure 5E). However, starting 8 hpi, cyclin
A-Cdk associated with wtp53-transactivated p21 until
16 hpi and correlated with the observed reduced kinase
activity (Figure 6C).
In contrast, in Flag-mutp53-expressing cells, p21 as-
sociated with cyclin A-Cdk until 8 hpi (Figure 6D, panel
4), demonstrating that during the first 8 hpi induction of
p21 depends solely on p53. Consequently, downregu-
lation of the Cdk activity was observed (Figure 6C),
most likely cyclin A-Cdk2, since cyclin A-Cdk1 com-
Cell
28Figure 6. p53-Transactivated p21 Downregulates Cyclin A-Cdk2 Activity
(A and C) Dox-induced, G1/S-mock- or UV-irradiated wtp53 TO-CV-1-Flag-mutp53, -mutp53, null (−) cells were harvested at the indicated
time points (x axis) and subjected to target bound cyclin E-Cdk2 (A) and cyclin A-Cdk2/1 (C) assays. The relative amount of kinase activity
normalized to the kinase activity measured from cells at 0 hr is shown (y axis).
(B) Cdc25A protein level determined from Dox-induced, G1/S-UV-irradiated wtp53 TO-CV-1 cells as in (A) by Western blot.
(D) Analysis of cyclin A association with kinases Cdk2, Cdk1, and p21 in Dox-induced, G1/S-UV-irradiated wtp53 TO-CV-1 cells as in (A) by
IP-Western blot. Analysis of mock-treated wtp53 TO-CV-1 null cells is shown in the first panel.plexes were not detectable until 8 hpi (Figure 6D, pan- H
els 2 and 3). Moreover, starting 10 hpi, lack of functional t
wtp53 generated p21-free cyclin A-Cdk complexes and c
explains why the kinase activity increased earlier in w
wtp53 TO-CV-1-Flag-mutp53 than in null cells (Figure m
6C). However, untimely increase in cyclin A-Cdk activity c
presumably cyclin A-Cdk1 had no negative impact on t
p53-mediated S phase attenuation and further cell cy- S
cle progression (Figure S4B). n
Taken together, data imply that subsequent to irradia- h
tion at the G1/S transition p53 reduces the activity of a
S phas-specific cyclin A-Cdk2 and thus is responsible a
for S phase attenuation, whereas p53 downregulates d
the activity of S/G2- and G2-specific cyclin A-Cdk1. o
However, p53-mediated reduction of cyclin A-Cdk1 ac- p
tivity is dispensable for S phase attenuation and thus t
not essential for the ATR-intra-S phase checkpoint. i
r
(p53 Maintains the ATR-Intra-S Phase Checkpoint
wto Promote Coordinated Repair and Replication
wThe physiological consequences of the p53-mediatedS phase attenuation were analyzed in more detail.ence, DNA repair and replication events were moni-
ored in G1/S-UV-irradiated wtp53 CV-1 and TO-CV-1
ells. First, the kinetics of undisturbed DNA replication
as determined in all cell lines. As expected, in all
ock-treated cell lines, 3H incorporation into DNA in-
reased immediately and ceased 8 hr later, indicating
hat DNA replication was complete (Figures 7A and
7A). However, in irradiated wtp53 CV-1 and TO-CV-1
ull cells, DNA replication was blocked for the first 2
r and incorporation of 3H into DNA remained low for
dditional 4 hr (Figures 7B, top, and S7B). Six hours
fter irradiation, the replication activity increased sud-
enly and ceased 6 hr later, indicating that the duration
f the replicative S phase, which is normally 8 hr, was
rolonged for 4 hr (Figures 7B, top, and S7B). In con-
rast, in irradiated Flag-mutp53-expressing cells, 3H
ncorporation into DNA was only delayed for 2 hr and
eplication activity ceased 8 hr after the G1/S transition
Figure 7B, middle). Thus, the overall replication time
as not prolonged in mutp53 cells. In contrast, in
tp53 TO-CV-1-Flag-mutp53 cells, which have inacti-vated endogenous wtp53 but functional p53, S phase
p53, Component of the Intra-S Phase Checkpoint
29Figure 7. Uncoupling of Repair and Replication Activities Depends on Functional p53
(A) 3H incorporation (left panel) was measured in Dox-induced, G1/S-mock treated wtp53 TO-CV-1 null cells. Cells were labeled with 3H for
60 min at the indicated times thereafter (x axis) and the resulting ratios of 3H cpm to g DNA were a measure of DNA synthesis (y axis).
Alkaline comet assay (right panel) was performed at the indicated time points (x axis); the relative olive tail moment, which reflects ssDNA
breakage, is depicted on the y axis.
(B) 3H incorporation (left panels) was measured in Dox-induced, G1/S-UV-irradiated wtp53 TO-CV-1 null, -Flag-mutp53, and -mutp53 cells
to determine replication activity as in (A). Alkaline comet assays (right panels) were carried out as in (A).
(C) Schematic representation of replication and repair events of Dox-induced, G1/S-mock- or -UV-irradiated wtp53 TO-CV-1 cell lines.was prolonged from 8 hr to 12 hr (Figure 7B, bottom).
Taken together, data show that p53/p53-independent
downregulation of cyclin E-Cdk2 activity inhibits DNA
replication only for 2 hr. However, inhibition of DNA rep-
lication for additional 4 hr depends on p53-mediated
reduction of cyclin A-Cdk activity via p21.
The observed delayed onset of rapid DNA replication
for 6 hr in wtp53 cells suggested that the additional
time might be used for repair. Therefore, DNA repair
activity was examined by monitoring the decrease of
relative amounts of DNA damage applying the alkaline
comet assay (Olive and Durand, 1992). The assay mea-
sures single-strand (ssDNA) DNA breakage that is gen-
erated by nucleotide excision repair. Following mock or
UV-irradiation at the G1/S transition, ssDNA breakage
was assessed at the indicated time points. In mock-
treated cells, the median tail moments demonstrate
that the ssDNA signal, which derives mainly from the
40 nucleotide long RNA-DNA primers that are gener-
ated by DNA polymerase α-primase during the initiation
and elongation replication process, correlates with the
graph obtained from 3H incorporation (Figures 7A andS7A). Thus, in mock-treated cells, the ssDNA signal re-
flects DNA replication activity. In contrast, in irradiated
wtp53 CV-1 and TO-CV-1 null cells, the median tail mo-
ments show that the ssDNA signal peaks at 1 and 8 hpi
(Figures 7B, top, and S7B). Data indicate that the first
ssDNA signal is generated by repair activity, whereas
the second one derives from replication priming events
since the second ssDNA signal matches the kinetics of
DNA synthesis (Figures 7B, top, and S7B). In irradiated
wtp53 TO-CV-1-Flag-mutp53 cells, the kinetics of the
ssDNA signal also shows two activity peaks (Figure 7B,
middle). However, the second ssDNA signal has its
maximum 10 hpi, occurs during G2 attenuation (Figure
5E), and does not match the kinetics of DNA replication.
Thus, in cells devoid of functional p53, the first ssDNA
signal derives from simultaneous DNA repair and repli-
cation activities, whereas the second one reflects repair
activity subsequent to activation of the G2 checkpoint.
Finally, irradiation of Flag-mutp53-expressing cells dem-
onstrated that wtp53 is not required to promote uncou-
pling of repair and replication events (Figure 7B, bottom).In summary, data suggest that the UV-induced ATR-
Cell
30intra-S phase checkpoint consists of two distinct com- T
aponents that cooperate to uncouple repair and replica-
tion events. With the first one, the 2 hr initiation phase c
ais p53/p53 independent and with the second one, the
4 hr maintenance phase depends on the transcriptional
sactivity of p53.
i
eDiscussion
c
sWe identified a novel p53 isoform (p53) at the mRNA
nand protein level that is generated by alternative exon
csplicing. Due to alternative splicing, 66 residues ex-
wtending from 257 to 322 are missing in p53. However,
wp53 has the entire tetramerization domain, enabling
tthe protein to oligomerize with itself, but surprisingly
lnot with p53. Despite the fact that p53 lacks 39 resi-
adues of the core domain that are within conserved re-
ggion V, p53 associates with and transactivates certain
Tp53-inducible promoters. Additionally, p53 also lacks
Sthe entire hinge region, a short linker between the spe-
pcific DNA binding domain and the tetramerization do-
amain, which is involved in the allosteric regulation of
CDNA binding (Waterman et al., 1995). As shown pre-
dviously, germline-derived hinge domain p53 mutants
ohave lost apoptotic but not cell cycle arrest functions,
dindicating that the hinge domain plays an important role
hin regulating p53 functions (Aurelio et al., 2000; Kong et
ial., 2001). In fact, subsequent to γ or UV irradiation,
pp53 associated and transactivated the p21 and 14-3-
d3s, but not the mdm2, bax, and PIG3 promoter. Thus,
op53 transactivates p53 target genes only that are in-
dvolved in cell cycle arrest functions and, therefore, dis-
nplays differential transcriptional activity per se.
aThe first evidence that p53 is of physiological rele-
evance derived from p21 promoter binding studies per-
Dformed with wtp53 CV-1 cells that were irradiated at
Ddiscrete cell cycle stages. Results demonstrate that
asubsequent to irradiation at the G1/S transition, p53
ubound and transactivated the p21 promoter, indicating
sthat the differential transcriptional activity operates in
ddamaged S phase cells. Moreover, cell cycle-depen-
tdent p21 promoter binding was also observed for p53
tsince promoter bound p53 was retrieved from irradi-
bated G1 and G2, but not from S phase cells. Transcrip-
ttionally impaired p53 might be beneficial for S phase
tcells in general, since induction of the full-scale p53
ttranscription program within the replicative phase could
promote unwanted cell death (Gottifredi et al., 2001).
Thus, S phase-specific p53, which has limited tran- E
scriptional activity capacity per se, allows upregulation
of p21 without risking transactivation of proapoptotic C
Tgenes such as bax and PIG3.
sFirst attempts to elucidate the regulatory mecha-
Anisms, which regulate the transcriptional activity of
5
both p53 proteins in damaged S phase cells pointed to n
the ATR-mediated signal transduction pathway, since A
ainactivation of endogenous ATR produced active p53,
Dbut inactive p53. However, regulation of transcrip-
ftional activation of p53 does not just involve stress-
minduced modifications but also physical and functional
s
interactions with chromatin-modifying cofactors such t
as histone-acetyltransferases p300 and CBP (Barlev et f
(al., 2001; Espinosa and Emerson, 2001; An et al., 2004).herefore, a complex regulatory network, which still
waits clarification, must be involved in controlling the
ell cycle-dependent transcriptional activity of p53
nd p53.
The UV-induced ATR signaling pathway causes tran-
ient delays in S phase progression and reversible
nhibition of DNA replication for several hours. How-
ver, the previously elucidated ATR-Chk1-Cdc25A-
yclin E-Cdk2 pathway inhibits replication only for a
hort time (Bartek et al., 2004). Thus, this event could
ot account for the 6 hr ongoing inhibition of DNA repli-
ation, indicating the existence of an additional path-
ay. We show that the key player of this pathway,
hich allows extended S phase attenuation and inhibi-
ion of replication is p53; its transcriptional activity
eads to p21-mediated downregulation of cyclin A-Cdk2
ctivity, an activity that is required for S phase pro-
ression and DNA synthesis (Hunter and Pines, 1994).
herefore, at least two parallel branches of the intra-
phase checkpoint cooperate to slow down S phase
rogression and to prevent origin firing, both of which
re controlled by the ATR signaling pathway. The
dc25A-cyclin E-Cdk2 pathway is executed rapidly, in-
ependently of p53 and p53, but prevents origin firing
nly for 2 hr. The other slower-operating branch, which
epends on the p53-p21-cyclin A-Cdk2 pathway, in-
ibits DNA replication for additional 4 hr. Apart from the
nhibition of replication, the ATR-p53-p21-cyclin A-Cdk2
athway provides another critical function: the repair of
amaged DNA before DNA is duplicated. The importance
f p53 for the ATR-intra-S phase checkpoint was
emonstrated by the fact that inactivation of endoge-
ous wtp53 prevented downregulation of cyclin A-Cdk2
ctivity, resulting in coupled repair and replication
vents. Moreover, cells deficient in p53 accumulated
NA damage that derived from inappropriately repaired
NA due to simultaneous repair and replication events
s indicated by subsequent repair activity during atten-
ated G2 progression. Although the G2 checkpoint
hould capture any cells that have exited S phase with
amaged DNA, these cells may have already missed
heir best opportunity to perform error-free repair. Thus,
he ATR-intra-S phase checkpoint, through the com-
ined action of the Chk1-Cdc25A-cyclin E-Cdk2 and
he p53-p21-cyclin A-Cdk2 pathways, allows repair of
he damaged DNA before replication is initiated in order
o ensure genetic integrity of the replicated DNA.
xperimental Procedures
ell Culture, Synchronization, and Treatment
he following cell lines were grown according to the supplier’s in-
tructions: CV-1 (African green monkey epithelial kidney cell line;
TCC#CCL70) and H1299 (human lung carcinoma; ATCC#CLR-
803). HSC93 cells (human B cell lymphoma) were grown as spin-
er culture in RPMI-1640 + 10% FCS and 2 mM glutamine at 37°C.
ll other cell lines are listed in the Supplemental Data. Cells were
rrested in G0/G1 phase by incubation with isoleucine-depleted
MEM + 5% FCS for 38 hr, released by exchanging the medium
or complete DMEM + 5% FCS, and cell cycle progression was
onitored by fluorescence-activated cell sorting (FACS) as de-
cribed (Dehde et al., 2001). The onset of DNA synthesis (G1/S
ransition) was determined by pulse-labeling the culture 20 min be-
ore fixation with the thymidine analog 5-bromo-2#-deoxyuridine
BrdU) (0.1 mM; Sigma) followed by immunostaining (Dehde et al.,
p53, Component of the Intra-S Phase Checkpoint
312001). Synchronized cells reached G1/S 9 hr after release from the
isoleucine block. Cells were γ irradiated (10 Gy) using a 137Cs
source or UV irradiated (10 J/m2; Stratagene Stratalinker) as indi-
cated. Caffeine (Sigma) was added to the culture medium (final
concentration 5 mM) 30 min before irradiation.
RT-PCR and Sequencing Analysis
Total RNA was isolated by the acid-guanidinium-phenol-chloroform
method (Chomczynski and Sacchi, 1987). Reverse transcription re-
actions were run with 1–2 g of total RNA using the Superscript
Preamplification System (Invitrogen Life Technologies) according to
manufacturer’s instructions. Reactions were performed with poly-
dT and random hexamer primers for the cDNA synthesis. The cDNA
was amplified in two rounds of PCR to detect C-terminal p53 splice
variants. The following p53-specific primer sets were used: for the
first round PCR the primers E4F (5#-CTCCTGGCCCCTGTCATCGT-
3#) and E11R (5#-GCTCAGTGGGGGAACAAGAAC-3#) and for the
nested PCR the primers E6/7F (5#-TGAGGTTGGCTCTGACTGTA-
3#) and E11bR (5#-AGAATGTCAGTCTGAGTCAGG-3#). PCR prod-
ucts were loaded on a 1% agarose gel, bands were sliced from the
gel, and DNA was purified with QIAEX II gel extraction kit (Qiagen).
All PCR products were analyzed by direct sequencing with an auto-
mated ABI PRISM 377 DNA sequencer using the ABI PRISM dye-
primer cycle-sequencing chemistry.
Cloning of wtp53 and mutp53 cDNA and Plasmids
The cDNA of human 984 bp wtp53 (HSC93) was generated by
PCR with specific primers: p53F-Eco (5#-TATATGAATTCGGGATCC
CATGGAGGAGCCGCAGTCAGA-3#) and p53R-Eco (5#-TATATGAA
TTCGGTCAGTCTGAGTCAGGCCCTTCTGTCT-3#) and cloned into
the EcoRI site of pcDNA3 (Invitrogen). The 175D mutation in human
wtp53 was introduced into pcDNA3-wtp53 using the Quick
Change Method (Quick Change kit, Stratagene) according to the
manufacturer’s instructions. The sequence accuracy of wtp53
and mutp53 was verified by sequencing. Mutp53-273H was ex-
cised from the pC53.273 plasmid with EcoRI and cloned into the
EcoRI site of pcDNA3. p53 proteins were Flag tagged by inserting
their cDNAs into the BamHI/ApaI site of the mammalian expression
vector pCMV-Tag2B (Stratagene). For doxycycline (Dox)-inducible
expression of proteins, the cDNAs from wt/mutp53 and wt/
mutp53 were excised with ApaI/NotI from the pCMV-Tag2B vector
and Flag-ATRkd was excised from the pcDNA3 plasmid with
BamHI/XhoI and subcloned into the pcDNA4/TO vector (T-Rex sys-
tem, Invitrogen).
Establishing Inducible TO Cell Lines
T-Rex is a Tet-regulated mammalian expression system based on
the binding for tetracycline or Dox to a Tet repressor (TR) resulting
in promoter activation of the appropriate Tet-inducible gene. p53
null H1299 cells were cotransfected with pcDNA6/TR encoding TR
and pcDNA4/TO vectors containing wtp53, mutp53-273H, wtp53,
mutp53-175D, or no p53 (empty vector). CV-1 cells were cotrans-
fected with the vectors pcDNA6/TR and pcDNA4/TO containing
Flag-tagged p53/p53 cDNA as mentioned above, empty vector, or
mutant ATRkd cDNA. Blasticidin- and Zeocin-resistant clones were
selected after 2 weeks. For each inducible TO cell line, between 50
and 70 clones were isolated and characterized. Clones, expressing
the appropriate protein only in the presence of Dox (1 g/ml), were
used in the experiments.
Chromatin Immunoprecipitation Assay (ChIP-PCR)
ChIP was performed with 106 cells per assay, according to the
manufacturer’s instructions (Upstate Biotechnology). The primers
used to determine the levels of p21, 14-3-3s, mdm2, bax, and PIG3
promoter DNA are listed in the Supplemental Data. PCR products
were separated in a 1.5% TBE-agarose gel and DNA was visualized
by ethidium bromide staining.
DNA Synthesis and Comet Assay
Cells at the G1/S transition were either mock or UV irradiated and
duplicate samples of cells pulse labeled with 7 Ci [3H]thymidine
(77 Ci/mmol; ICN Biomedicals) per ml of culture medium for 60
min at the indicated time points. 3H incorporation was stopped bywashing cells twice in ice-cold phosphate-buffered saline (PBS)
before scraping them into 1 ml of ice-cold PBS. Cells were col-
lected by centrifugation, and total DNA was isolated using a
NucleoSpin Tissue kit (Macherey-Nagel) according to the manufac-
turer’s instructions. DNA concentration was measured at 260 nm
and 3H incorporation was determined by liquid scintillation count-
ing. The resulting ratios of 3H cpm to g DNA were a measure of
DNA synthesis. The repair assay, specific for ssDNA was carried
out as described (Olive and Durand, 1992). A brief description of
the Comet assay is provided in the Supplemental Data.
Immunological Reagents
The following primary antibodies were used: anti-p53 monoclonal
antibodies DO1 (Oncogene), DO12, ICA9 (Serotec); anti-p53 rabbit
polyclonal antibody SAPU (S238-120; Scottish Antibody Produc-
tion Unit, Lanarkshire, Scotland); rabbit polyclonal antibodies anti-
bax, anti-cdk2, anti-Cdc25A (Upstate Biotechnology); monoclonal
antibodies anti-mdm2 (SMP14), anti-cdk1 (1), anti-cyclin E (HE67)
(BD Biosciences); anti-pig3 rabbit polyclonal antibody (Ab-1), anti-
cyclin A monoclonal antibody (Ab-3) (Oncogene); rabbit polyclonal
antibodies anti-p21 (H-164), anti-cyclin A (H-432), anti-14-3-3σ goat
polyclonal antibody (N-14) (Santa Cruz); anti-Flag monoclonal anti-
body (M2) (Sigma); rabbit polyclonal antibodies anti-phospho-p53-
serine 15, anti-phospho-Chk1-serine 345 (Cell Signaling Tech-
nology).
Protein Manipulations
Immunoprecipitation and -blotting were performed as described
(Dehde et al., 2001). Oligomerization of p53 and p53 was analyzed
in wtp53 TO-CV-1 cells expressing Flag-tagged wt/mutp53 or wt/
mutp53. The anti-Flag-derived protein complexes were separated
by 10% SDS-PAGE (30% acrylamide + 0.5% bis-acrylamide) and,
bound endogenous wtp53 or wtp53 was visualized by Western
blot.
Histone H1 Kinase Assay
G1/S-mock- or UV-irradiated cells were used to assess the time
course of cyclin E-Cdk2 and cyclin A-Cdk2/1 activities. Three hun-
dred micrograms of lysate was incubated with specific anti-cyclin
E and -cyclin A monoclonal antibodies. The immunoprecipitates
were assayed for kinase activity with 1 g of histone H1 added as
substrate in histone-kinase buffer (Dehde et al., 2001) for 30 min at
37°C. Reactions were stopped with 20 l 2× SDS sample buffer for
20 min at 60°C, separated by 10% SDS-PAGE, and 32P incorpora-
tion into H1 was quantified by using phosphoimage analysis (Amer-
sham Pharmacia).
Supplemental Data
Supplemental Data include seven figures and Supplemental Exper-
imental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/122/1/21/DC1/.
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